The VersaLink Fixation System is a bilateral titanium lumbar fusion be used for be used for use in conjunction with a titanium crossbar as standalone fusion tadalafil click here . It will also connect above or below the company’s flagship TOPS device as a hybrid construct. The VersaLink Fixation System to treat patients with a broad spectrum of spinal disorders including degenerative disc disease , herniated disc, spinal stenosis, and spondylolisthesis. The VersaLink Fixation System CE approval received but not currently approved for sale in the United States.
About Impliant,Impliant, a privately held company is engaged in the development of novel spine arthroplasty solutions to some of the most frequent pathologies of the spine. The company’s flagship product is the TOPS System, which has is the longest clinical history in the Total Posterior Arthroplasty market segment, dated January 2005. Impliant is also developing the VersaLink Fixation System, the TOPS – SP system, and some others of the next generation and multi-level technologies to further increase the addressable market. Impliant is in Princeton, NJ with research facilities located in Ramat Poleg, Israel. Shareholders are Elron Electronic Industries Ltd. .
The primary efficacy end point of at both studies, the non inferiority of of edoxaban to enoxaparin sodium had confirmed to the prevention of asymptomatic and symptomatic deep venous thrombosis and symptomatic pulmonary embolism. The primary safety endpoint in both studies the incidence of severe and clinically relevant non-major haemorrhage among edoxaban and compared to enoxaparin sodium were at comparison groups.